CBIZ Investment Advisory Services’s DexCom DXCM Stock Holding History

CBIZ Investment Advisory Services’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8	Closed	-$538	–	780
2025 Q3	$538	Hold	8	–	–	﹤0.01%	639
2025 Q2	$698	Buy	+8	New	+$627	﹤0.01%	618

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CBIZ Investment Advisory Services's DXCM Position: Q4 2025 in Review

CBIZ Investment Advisory Services sold out of DexCom (DXCM) in Q4 2025, closing a stake of 8 shares — an estimated $538 sold.

CBIZ Investment Advisory Services first reported a position in DXCM in Q2 2025 and held it in 2 quarters. The position peaked at $698 in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

CBIZ Investment Advisory Services reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
CBIZ Investment Advisory Services sold 8 DexCom shares in Q4 2025, an estimated $538.
CBIZ Investment Advisory Services first reported a position in DexCom in Q2 2025 and held it in 2 quarters.
CBIZ Investment Advisory Services's DexCom position peaked at $698 in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on CBIZ Investment Advisory Services's 13F filing for Q4 2025, filed 9 Feb 2026.